PT  - JOURNAL ARTICLE
AU  - Kamran Najeebullah
AU  - Jessica Liebig
AU  - Jonathan Darbro
AU  - Raja Jurdak
AU  - Dean Paini
TI  - Efficient Surveillance and Temporal Calibration of Disease Response
AID  - 10.1101/2021.01.13.21249781
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.01.13.21249781
4099  - http://medrxiv.org/content/early/2021/01/20/2021.01.13.21249781.short
4100  - http://medrxiv.org/content/early/2021/01/20/2021.01.13.21249781.full
AB  - Background Disease surveillance and response are critical components of epidemic preparedness. The disease response, in most cases, is a set of reactive measures that follow the outcomes of the disease surveillance. Hence, efficient surveillance is a prerequisite for an effective response.Methodology/Principal Findings We introduce the principle of epidemiological soundness and utilize it to construct a disease spread network. The network implicitly quantifies the fertility (whether a case leads to secondary cases) and reproduction (number of secondary cases per infectious case) of the cases as well as the size and generations (of the infection chain) of the outbreaks. We empirically confirm that high morbidity relates positively with delay in disease response. Moreover, we identify what constitutes efficient surveillance by applying various thresholds of disease response delay to the network and report their impact on case fertility, reproduction, number of generations and ultimately, outbreak size. Lastly, we identify the components of the disease surveillance system that can be calibrated to achieve the identified efficiency thresholds.Conclusion We identify practically achievable, efficient surveillance thresholds (on temporal scale) that lead to an effective response and identify how they can be satisfied. Our approach can be utilized to provide guidelines on spatially and demographically targeted resource allocation for public awareness campaigns as well as to improve diagnostic abilities and turn-around times for the doctors and laboratories involved.Author Summary Efficient surveillance and effective response capabilities are pivotal to the prevention and control of the infectious diseases. The disease response is a set of reactive actions that follow the outcomes of the disease surveillance. Ergo, efficient surveillance is a perquisite for the deployment of an effective response. The quantification of the efficiency of a disease surveillance system largely depends on the epidemiological characteristics of the disease. In this paper, we introduce an approach that builds on these characteristics and measures the performance of a disease surveillance system through its impact on the incidence of the disease. Using this approach, we obtain quantitative (on a temporal scale) efficient surveillance thresholds, which if followed by a timely response, lead to a considerable reduction in the disease incidence. Furthermore, we show that these thresholds are practically achievable by identifying the obstacles that lead to less than efficient surveillance outcomes. Our approach can be applied to obtain guidelines on spatially, temporally and demographically targeted resource allocations for public awareness campaigns as well to improve diagnostic ability and turn-around times in treating doctors and pathology labs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded internally by the Health and Biosecurity unit of Commonwealth Scientific and Industrial Research Organization of Australia.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the CSIRO Social Science Human Research Ethics Committee (Ethics Clearance 065/19) and by the Health Innovation, Investment and Research Office (HIIRO) under section 284 of the Public Health Act 2005 (grant number: RD007950).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets underlying the results of this study are available at the discretion of the data custodians due to associated legal, ethical and privacy concerns. The access to dengue occurrence data is restricted by Queensland Health in accordance with the Public Health Act 2005. Interested parties can request access through the Communicable Diseases Branch of Queensland Health (email: epi{at}health.qld.gov.au). The IVS and NVS data can be obtained from Tourism Research Australia (email: tourism.research{at}tra.gov.au). Weather data can be obtained upon request from Bureau of Meteorology (http://www.bom.gov.au/climate/data-services/data-requests.shtml). All the source code necessary to replicate the presented results is available upon request on a case-to-case basis due to commercial considerations.